Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06910059 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The CT-verified Data Collection Study to Investigate the Correlation Between the Leadless Pacemaker Tip Location and Echo, ECG

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 1, 2026 (before its estimated August 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Apr 30, 2026 to Aug 31, 2026
    • Study completion date: Jun 30, 2026 to Aug 31, 2026
    v3
  2. Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Start date changed from estimate of Apr 15, 2025 to Jun 17, 2025
    • Site contact updated
    • Publications: details revised at 3 of 3 entries
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to assess inter-/intra- ventricular synchrony and ECG characteristics in relation to Micra tip location. The secondary objective is (1) to identify an optimal Micra pacing location to improve LV function, (2) to investigate the correlation between Micra tip location and tricuspid regurgitation, and (3) to investigate whether Micra location would impact AV synchrony. Patients with pacing indications who plan to receive Micra AV implantation will be recruited.
Trial Details
NCT Number NCT06910059
Lead Sponsor Medtronic Cardiac Rhythm and Heart Failure
Conditions
(from sponsor)		 Bradycardia Sinus, AV Block, Atrial Fibrillation (AF)
Related terms Atrial Fibrillation, Atrioventricular Block
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov